| Bladder Neoplasm studied in …STUDIED_INderived200 of 1,701show all (up to 200) |
|---|
| → studied in | NCT02465060Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped CURATED_BROADER · 1,701 trials mapped (526 active) | — | — | Bladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04502095Phase 4 · completed Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05891171Phase 1 · active not recruiting Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05987241Phase 2/Phase 3 · recruiting Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07061964Phase 2 · recruiting Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04235764recruiting En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04235777Phase 1 · active not recruiting Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05007106Phase 2 · completed MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005) · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06331299Phase 3 · active not recruiting A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06770582Phase 2 · recruiting Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06833073Phase 2 · recruiting A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011) · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06919965Phase 3 · recruiting A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07180212NA · active not recruiting Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07277413Phase 1 · recruiting A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00745355active not recruiting Quality of Life in Patients With Bladder Cancer · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04640623Phase 2 · active not recruiting A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guérin Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04658862Phase 3 · active not recruiting A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05316155Phase 1/Phase 2 · active not recruiting Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05714202Phase 3 · active not recruiting A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC) · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06172478Phase 2 · recruiting A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06211764Phase 3 · active not recruiting A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG) · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06319820Phase 3 · recruiting A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06877676approved for marketing Pre-Approval Expanded Access Study for TAR-200 Treating Physician Use · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07124000recruiting DESTINY-PANTUMOUR04 · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07309445recruiting A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07419295Phase 3 · recruiting A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031) · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07735793not yet recruiting A Study of Radical Cystectomy in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) and Muscle Invasive Bladder Cancer (MIBC) in Korea · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06290687Phase 2 · withdrawn Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06605404recruiting Pan-tumor MRD Study · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07217496Phase 1 · not yet recruiting N-803 in Combination With Pembrolizumab and Enfortumab Vedotin for Treatment of Urothelial Cancer · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07800507Phase 1/Phase 2 · not yet recruiting Trop2-Targeted Near-Infrared Fluorescence Imaging-Guided Precise Resection of Non-Muscle Invasive Bladder Cancer · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04963153Phase 1 · active not recruiting Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy · condition mapped CURATED_BROADER · 1,701 trials mapped (526 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06703476Phase 3 · recruiting A Study of Surgical Techniques During Cystectomy · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06814496Phase 1/Phase 2 · recruiting Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07218380Phase 3 · recruiting A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04503577recruiting Prospective Bladder Cancer Infrastructure (ProBCI) · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04506554Phase 2 · active not recruiting A Study of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04644068Phase 1/Phase 2 · active not recruiting Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06529822Phase 1 · recruiting Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease · condition mapped PROBABILISTIC · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07638410NA · recruiting Prehabilitation in High-risk Oncologic Surgery · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07804056Phase 3 · recruiting A Study to Investigate the Efficacy and Safety of Alpha1H as a Neoadjuvant Therapy in Participants With Low- to Intermediate-Risk/Low-Grade Papillary Non-Muscle Invasive Bladder Cancer · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07829783Phase 3 · not yet recruiting A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) and Pembrolizumab (MK-3475A) in Participants With Bladder Cancer (MK-2870-055) · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06227065Phase 2 · not yet recruiting Precise Chemoresection in Low-grade NMIBC Using Drug Screens in Patient-derived Organoids · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07827612Phase 2 · not yet recruiting A Study of Vepugratinib (LY3866288) in Adults With Non-Muscle Invasive Bladder Cancer and Upper Tract Urothelial Cancer · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02704832NA · completed Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE) · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06394570Phase 1/Phase 2 · recruiting Enfortumab Vedotin and Stereotactic Radiation for Localized, Cisplatin Ineligible Muscle Invasive Bladder Cancer · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06733363Phase 2 · recruiting A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer · condition mapped PROBABILISTIC · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07332351Phase 2 · not yet recruiting Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle Invasive Bladder Cancer, TRIFECTA Trial · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07667335Phase 1/Phase 2 · recruiting Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer · condition mapped CURATED_BROADER · 1,701 trials mapped (526 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04579224Phase 3 · active not recruiting Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer · condition mapped CURATED_BROADER · 1,701 trials mapped (526 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04940299Phase 2 · active not recruiting Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma · condition mapped CURATED_BROADER · 1,701 trials mapped (526 active) | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05464576NA · recruiting Tumor Staging T of Bladder Tumours: Correlation of MRI and Anatomopathologic Analysis · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05796375Phase 2 · recruiting Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07822373Phase 2 · not yet recruiting A Phase 2 Study Evaluating Bladder Preservation With Enfortumab Vedotin Plus Pembrolizumab in Patients With Muscle-Invasive Urothelial Cancer · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05538663Phase 3 · active not recruiting Intravesical BCG vs GEMDOCE in NMIBC · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07217171Phase 1 · recruiting A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07341737Phase 1/Phase 2 · recruiting SL-28 for Advanced Solid Tumours · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07777848Phase 2 · not yet recruiting A Study to Evaluate the Efficacy and Safety of RAG-01 as Monotherapy and in Combination With Chemotherapy in Patients With Non-muscle Invasive Bladder Cancer (NMIBC). · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07820566recruiting Development of a Preclinical 3D Vascularized and Perfused Tumoroid Model in Oncology and Urology Developed From Patient Tumors (Kidney, Bladder, and Prostate Cancers) · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07821177early Phase 1 · active not recruiting Bladder Preservation or Cystectomy for MIBC · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02812420early Phase 1 · active not recruiting Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Invasive Bladder Sarcomatoid Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05014139Phase 1 · terminated A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC) · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05059444recruiting ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05858736Phase 1 · completed Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06503614Phase 2 · recruiting A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer · condition mapped PROBABILISTIC · 1,701 trials mapped (526 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07038928recruiting TReatment Approaches and bIomarkers preValence in bladdEr Cancer in RuSsian Federation · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07817173NA · not yet recruiting Feasibility of HISA During TURBT for NMIBC · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06443944available An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06990061NA · recruiting Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer: an Open-label, Single-arm, Multicentre, Phase 2 Study · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07222488Phase 1/Phase 2 · recruiting A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003) · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07566156Phase 3 · recruiting Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309) · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02496208Phase 1 · active not recruiting Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Bladder Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03661320Phase 3 · completed A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder Cancer · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06040762NA · recruiting A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07548476NA · recruiting Acupuncture and Exercise for EV-Pembro-Induced Peripheral Neuropathy · condition mapped CURATED_BROADER · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00365157Phase 1/Phase 2 · active not recruiting Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction · condition mapped CURATED_BROADER · 1,701 trials mapped (526 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02675829Phase 2 · completed Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00001823recruiting Evaluation for NCI Surgery Branch Clinical Research Protocols · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07148765NA · active not recruiting Use of Wearables Following Cystectomy- Part II · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07189793Phase 2 · not yet recruiting Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06465069Phase 1 · recruiting A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07090499Phase 1 · recruiting A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07144319recruiting Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07463963NA · recruiting Relevance of the Urine Bacterial Culture Performed Before TransUrethral Resection of the Bladder for Post-operative Febrile Urinary Tract Infections Prevention: a Non-inferiority Randomized Controlled Trial · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06337084Phase 1 · active not recruiting Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06567743Phase 2 · recruiting Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06617169Phase 1 · active not recruiting Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07414992Phase 2 · withdrawn A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02657486NA · completed BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder · condition mapped PROBABILISTIC · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04917809Phase 2 · active not recruiting A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05334069recruiting Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05704244Phase 3 · active not recruiting Safety and Efficacy of FE 999326 Administered Intravesically to Japanese Subjects With High-grade, BCG Unresponsive, Non-muscle Invasive Bladder Cancer (NMIBC) · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05837767NA · recruiting A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05864144Phase 1/Phase 2 · completed A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06904365recruiting Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06972771recruiting Trop2-targeting NIR-II Molecular Probe for Guided Identification of Non-Muscle-Invasive Bladder Cancer · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06995898NA · recruiting The Vanguard Study: Testing a New Way to Screen for Cancer · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07232602Phase 1/Phase 2 · recruiting KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04) · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07798479completed Age and Bladder Cancer Outcomes After BCG Treatment: A Multicenter Study · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02625961Phase 2 · terminated Study of Pembrolizumab (MK-3475) and Pembrolizumab With Other Investigational Agents in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057) · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00026884recruiting Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02379429recruiting Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03244384Phase 3 · active not recruiting Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer · condition mapped CURATED_BROADER · 1,701 trials mapped (526 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03775265Phase 3 · active not recruiting Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05567185Phase 1 · active not recruiting A Study of Erdafitinib Intravesical Delivery System in Japanese Participants With Bladder Cancer · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07781852early Phase 1 · not yet recruiting Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07782164recruiting Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study) · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07784387recruiting A Study to Characterize High-Risk Non-Muscle-Invasive Bladder Cancer Participants in Portugal · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07793318Phase 2 · not yet recruiting TR115 in ARID1A-Mutated Advanced Solid Tumors · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07660055Phase 1 · recruiting Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07180121enrolling by invitation Information Needs and Supportive Rehabilitation Over Time in Patients Undergoing Cystectomy in Bladder Cancer · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03258593Phase 1 · completed Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG) · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04670445NA · completed Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer · condition mapped CURATED_BROADER · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06414317NA · active not recruiting An Education and Navigation Support Tool to Improve Participation in Care Coordination Among Patients With Locally Advanced, Metastatic and Unresectable Bladder Cancer and Their Caregivers · condition mapped CURATED_BROADER · 1,701 trials mapped (526 active) | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07579195Phase 1/Phase 2 · recruiting Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07783815Phase 1 · not yet recruiting A Study to Evaluate the Efficacy and Safety of Intravesical Instillation of Disitamab Vedotin Combined With Toripalimab in Patients With HER2-Positive High-Risk Non-Muscle Invasive Bladder Cancer Who Are BCG-Naïve or Have BCG Failure · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00902590active not recruiting A Genotype-Phenotype Urothelial Cancer Registry · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03185468Phase 1/Phase 2 · terminated Intervention of Bladder Cancer by CAR-T · condition mapped PROBABILISTIC · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07781956NA · not yet recruiting Home-Based Supportive Care Program for NMIBC Patients Receiving Intravesical Perfusion: Construction and Preliminary Application · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07480356Phase 3 · recruiting Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04410302recruiting Patient-Derived Xenografts to Reduce Cancer Health Disparities · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05614739Phase 1 · recruiting FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3 · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07129993Phase 2/Phase 3 · recruiting Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07227077NA · recruiting Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03193970recruiting Measuring Surgical Recovery After Radical Cystectomy · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06059547Phase 2 · completed Neoadjuvant Immunotherapy Combined With the Anti-GDF-15 Antibody Visugromab to Treat Muscle Invasive Bladder Cancer · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02609269enrolling by invitation Decipher Genomics Resource for Intelligent Discovery · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07097142Phase 3 · recruiting Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05776758Phase 3 · active not recruiting Role of NAC in cT0 Muscle-invasive Bladder Cancer After Maximal TURBt · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06011954recruiting A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07762820NA · not yet recruiting REtrieval of Transurethrally Resected Intact En-bloc Vesical Tumors Using a Retrieval Device for Bladder Tumors · condition mapped PROBABILISTIC · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07187635NA · recruiting Guiding Value of Urinary Tumor DNA Testing in Repeat Transurethral Resection of Non-Muscle-Invasive Bladder Cancer · condition mapped PROBABILISTIC · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07726602recruiting Tumor-informed ctDNA in Muscle-invasive Bladder Cancer for Evaluation of Residual/Recurrent Disease - the TiMBER Trial · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07758881NA · not yet recruiting Evaluating the Safety and Performance of the Eight Medical Hyperthermia System IV 1.0 for HIVEC in NMIBC. · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06041503Phase 2 · recruiting Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE) · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Bladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06161532Phase 2 · recruiting Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C... · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Bladder Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07655284Phase 3 · withdrawn STENT X: a Randomized Trial to Assess Stent-free Radical Cystectomy · condition mapped PROBABILISTIC · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07762586Phase 2 · recruiting Luminal Bladder Cancer Effective Response to Neoadjuvant Chemotherapy (LUMBER-NAC) · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07763197recruiting Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive Bladder Cancer (SCORE-NMIBC) · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04164082Phase 2 · active not recruiting Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Bladder Flat Urothelial Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04179162Phase 1/Phase 2 · active not recruiting Bacillus Calmette-Guérin (BCG) and Gemcitabine in People With High-Grade Non-Muscle Invasive Bladder Cancer That Came Back After BCG Treatment · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06242470Phase 1 · recruiting A Study of MGC026 in Participants With Advanced Solid Tumors · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06891209recruiting Exploration of HRQOL and Urinary Outcomes Following Partial Cystectomy · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04923178recruiting A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07756008Phase 2/Phase 3 · not yet recruiting Bladder-Sparing Treatment With Disitamab Vedotin and Toripalimab With or Without Pelvic Lymph Node Dissection in Bladder Cancer · condition mapped PROBABILISTIC · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04752722Phase 1/Phase 2 · recruiting LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05137262Phase 2 · active not recruiting A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01050504recruiting Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer · condition mapped CURATED_BROADER · 1,701 trials mapped (526 active) | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05055050Phase 1 · active not recruiting A Window of Opportunity Phase I Study of UGN-201 in Patients With Bladder Cancer Undergoing Radical Cystectomy Protocol #: 2021-0630 · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05483868Phase 1 · active not recruiting A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06417190Phase 2 · recruiting Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07749924NA · not yet recruiting Active Surveillance Versus Adjuvant Intravesical Chemotherapy in Liquid Biopsy-Defined Low-Shedding Intermediate-Risk NMIBC · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03459846Phase 2 · active not recruiting A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU) · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06809140Phase 2 · recruiting Enfortumab Vedotin Plus Pembrolizumab With Selective Bladder Sparing for Treatment of Muscle-invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06910657Phase 1 · recruiting IDOV-Immune for Advanced Solid Tumors · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07000084Phase 3 · recruiting Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy · condition mapped CURATED_BROADER · 1,701 trials mapped (526 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05111574Phase 2 · active not recruiting Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Bladder Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06960577Phase 3 · recruiting Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2) · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03869190Phase 1/Phase 2 · terminated Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC) · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04934540recruiting The Global En Bloc Resection of Bladder Tumour Registry · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07724886NA · not yet recruiting Role of ERBT Plus Intravesical BCG in Intermediate-Risk or High-Risk NMBC · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03047213Phase 2 · active not recruiting Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations · condition mapped PROBABILISTIC · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03237780Phase 2 · active not recruiting Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer · condition mapped CURATED_BROADER · 1,701 trials mapped (526 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03854474Phase 1/Phase 2 · active not recruiting Testing the Addition of Tazemetostat to the Immunotherapy Drug, Pembrolizumab (MK-3475), in Advanced Urothelial Carcinoma · condition mapped CURATED_BROADER · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07225127recruiting Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2 · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07646847NA · recruiting A Study of a Side Effects and Resource Navigation Program for People With Cancer · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07739121recruiting Benchmarking Large Language Models Against Tumour Boards for Oncology Treatment Recommendations · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06963346Phase 1 · recruiting Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07285044Phase 2 · recruiting The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07735858active not recruiting Microfluidic Urinary Exosome-Based Diagnostic Model for Bladder Cancer · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05756569Phase 2 · recruiting Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Bladder Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07106762Phase 2/Phase 3 · recruiting Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07728474NA · recruiting LCS103 Herbal Formula for Secondary Prevention of Non-Muscle Invasive Urothelial Carcinoma of the Bladder · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07732686not yet recruiting Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07727343NA · not yet recruiting AI-Guided TURBT for Bladder Cancer · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03693014Phase 2 · active not recruiting A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03915678Phase 2 · active not recruiting Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07725796Phase 1 · not yet recruiting A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07721935recruiting Development of an AI-Agent for Urological Disease Diagnosis and Treatment · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03924856Phase 3 · completed Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866) · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04081246NA · completed Transurethral Modified En Bloc Resection For Large Bladder Tumours. · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07095751NA · not yet recruiting Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder Cancer · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05512377Phase 2 · completed Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07207824Phase 3 · recruiting DV+BCG in HER2-Expressing, BCG-Naïve High-Risk NMIBC · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07307456Phase 2 · recruiting Toripalimab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07717242Phase 2 · recruiting Sun Yat-Sen Treatment Strategy for Enhancing Response in Muscle-invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04706598Phase 1/Phase 2 · active not recruiting Safety and Efficacy of Camrelizumab for High-risk NMIBC Failing BCG Treatment · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05531123Phase 2 · active not recruiting Risk-stratification Based Bladder-sparing Modalities for Muscle-invasive Bladder Cancer · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05833867Phase 1 · recruiting Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer · condition mapped CURATED_BROADER · 1,701 trials mapped (526 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07424287Phase 3 · recruiting A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03504163Phase 2 · active not recruiting Pembrolizumab (MK-3475) and Bacillus Calmette-Guérin (BCG) as First-Line Treatment for High-Risk T1 Non-Muscle-Invasive Bladder Cancer (NMIBC) and High-Grade Non-Muscle-Invasive Upper Tract Urothelial Carcinoma (NMI-UTUC)] · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03732677Phase 3 · active not recruiting Durvalumab+ Gemcitabine/Cisplatin (Neoadjuvant Treatment) and Durvalumab (Adjuvant Treatment) in Patients With MIBC · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00848289active not recruiting Genetic Susceptibility to Bladder Cancer · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03744793Phase 2 · active not recruiting Pemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial Cancer · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Invasive Bladder Sarcomatoid Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04700124Phase 3 · active not recruiting Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-Eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304) · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05843448Phase 1 · active not recruiting IDO and PD-L1 Peptide Based Immune-Modulatory Therapeutic (IO102-IO103) in Combination With Pembrolizumab for BCG-Unresponsive or Intolerant, Non-Muscle Invasive Bladder Cancer · condition mapped PROBABILISTIC · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06955910completed Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies. · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03317158Phase 1/Phase 2 · active not recruiting Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06237920Phase 2 · active not recruiting Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab · condition mapped ALIAS · 1,701 trials mapped (526 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |